The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer

BACKGROUND: Decision‐making regarding adjuvant chemotherapy for early‐stage breast cancer can be guided by genomic assays such as OncotypeDX. The concordance of expected clinical decisions guided by OncotypeDX and prognostication online tools such as PREDICT is unknown. METHODS: We performed a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Daniel A., Mayer, Chen, Shochat, Tzippy, Reinhorn, Daniel, Moore, Assaf, Sarfaty, Michal, Yerushalmi, Rinat, Goldvaser, Hadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333833/
https://www.ncbi.nlm.nih.gov/pubmed/32372569
http://dx.doi.org/10.1002/cam4.3088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333833/
https://www.ncbi.nlm.nih.gov/pubmed/32372569
http://dx.doi.org/10.1002/cam4.3088

Ejemplares similares